Physician

Muhammad Omer Jamil, M.D.

According to 2025 Medicare claims, Muhammad Jamil, M.D. (NPI: 1245545508) practices hematology/oncology in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Cabell, WV. This provider's primary affiliated billing organization is CABELL HUNTINGTON HOSPITAL INC (NPI: 1104901784; TIN: 550675666) and primary practice location at 25701-4114.

Jamil's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 521 traditional Medicare patients, billed 2,602 HCPCS/CPT codes, and received $199,658 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,133 prescription claims across 342 beneficiaries totaling $7,984,111 in drug costs, led by Xtandi (Enzalutamide). DME data shows 92 claims. Open Payments data shows 3 records totaling $52. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $10,084 to $7,984,111. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $578 and ending at $2,646.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$139K$277K2016 Medicare payment: $66,948 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $191,232 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $240,773 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $277,243 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $231,591 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $205,662 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $151,675 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $175,311 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $199,658 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016236723$66,948
20174312,172$191,232
20184502,600$240,773
20195383,025$277,243
20204052,492$231,591
20214042,121$205,662
20224111,843$151,675
20235002,214$175,311
20245212,602$199,658

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.0M$8.0M2015 Drug cost: $10,084 (USD; Tot_Drug_Cst)2016 Drug cost: $448,603 (USD; Tot_Drug_Cst)2017 Drug cost: $1,785,095 (USD; Tot_Drug_Cst)2018 Drug cost: $2,779,325 (USD; Tot_Drug_Cst)2019 Drug cost: $4,591,339 (USD; Tot_Drug_Cst)2020 Drug cost: $4,139,901 (USD; Tot_Drug_Cst)2021 Drug cost: $3,678,720 (USD; Tot_Drug_Cst)2022 Drug cost: $3,973,601 (USD; Tot_Drug_Cst)2023 Drug cost: $5,054,336 (USD; Tot_Drug_Cst)2024 Drug cost: $7,984,111 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R65$10,084
201696348$448,603
20171811,378$1,785,095
20182311,854$2,779,325
20192672,172$4,591,339
20202271,897$4,139,901
20212161,608$3,678,720
20222371,437$3,973,601
20233151,880$5,054,336
20243422,133$7,984,111

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.7K$11K2017 Medicare payment: $212 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $7,917 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $11,328 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $7,635 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $11,377 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $9,637 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R12$212
2018N/R98$7,917
2019N/R155$11,328
2020N/R169$7,635
2021N/RN/RN/R
2022N/R201$11,377
2023N/RN/RN/R
2024N/R92$9,637

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes4751$136
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more135321$113
M0010Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services78423$80
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2781,262$72
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more173280$42

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide962,880$1,261,838
IbrancePalbociclib501,400$807,220
PomalystPomalidomide30840$718,126
VenclextaVenetoclax481,438$639,091
InlytaAxitinib26780$456,662

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
B4152Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unitNN/R19$5,132
B4034Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tapeNN/R17$2,119
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R11$1,457
J8521Capecitabine, oral, 500 mgNN/R14$478
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R17$276

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$52Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Muhammad Omer Jamil, M.D.?

Tedicare shows public-source Medicare data for Muhammad Omer Jamil, M.D. (NPI 1245545508), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Muhammad Omer Jamil, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Muhammad Omer Jamil, M.D.?

Muhammad Omer Jamil, M.D. is linked to CABELL HUNTINGTON HOSPITAL INC (billing NPI 1104901784) in the available physician profile data.

Does Muhammad Omer Jamil, M.D. have Open Payments data?

Muhammad Omer Jamil, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.